At least 171 million people worldwide have diabetes, a figure which is likely to double by 2030.

Prevalence of foot ulcers among patients diagnosed with diabetes mellitus is 4% to 10% and lifetime incidence may be as high as 25%. Diabetes is the most common case of nontraumatic amputation of the lower limb.

We are pleased to showcase the Pedyphar ointment which heals from Diabetic Foot Ulcers.

Pedyphar is an ointment that promotes healing by reversing the hypoxic and acidic environment in the wound added to its antimicrobial, immunomodulatory, nutritional and biochemical properties. Pedyphar has shown extraordinary results during clinical trials after 2 to 6 months. See below figures for real cases: